<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83550">
  <stage>Registered</stage>
  <submitdate>11/02/2009</submitdate>
  <approvaldate>11/05/2009</approvaldate>
  <actrnumber>ACTRN12609000240246</actrnumber>
  <trial_identification>
    <studytitle>2009 Cheese &amp; Sterols Study. A 15 week randomised study investigating the effects of phytosterol-rich cheese products on cardiovascular markers on people with hypercholesterolaemia.</studytitle>
    <scientifictitle>A 15 week randomised study investigating the effects of phytosterol-rich cheese products on cardiovascular markers on people with hypercholesterolaemia.</scientifictitle>
    <utrn />
    <trialacronym>KS</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>hypercholesterolemia</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will be randomised to 1 of 4 treatments of 3 week duration each and crossed over at the end of each 3 weeks to the alternative treatment (for all 4 treatments). Each intervention will be double blind. After each 3 week phase a 1 week washout period, where volunteers return to their regular dietary intake is followed. The test foods are either cream cheese or cheese slices as follows:
1. 1 mini-tub of 40gm cream cheese containing 2.0gm sterol esters each day,
2. 2 serves of 20.5gm cheese slice containing 2.0gm sterol esters each day,
3. 1 mini-tub of 40gm sterol free cream cheese each day,
4. 2 serves of 20.5gm sterol free cheese slice each day. The test foods are reduced in total fat and volunteers will be required to incorporate the test foods into their existing diet by replacing like foods. This is in anticipation of maintaining energy balance to support  weight maintenance throughout the study.</interventions>
    <comparator>Sterol free cream cheese and the sterol free cheese slice.</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Lowering of Low Density Lipoprotein cholesterol by blood analysis</outcome>
      <timepoint>weeks 0,3,7,11 and 15</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Carotenoid levels by blood analysis</outcome>
      <timepoint>weeks 0,3,7,11 and 15</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Body Mass Index (BMI) less than 35.
Total cholesterol greater than 5.0mmol/L and less than 7.5mmol/L.
Triglycerides less than 4.5 mmol/L.
Participants currently taking phytosterol fortified products are permissible provided they have a 3 week washout prior to study commencement.</inclusivecriteria>
    <inclusiveminage>35</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Person considered by the investigator to be unwilling, unlikely or unable to comprehend or comply with the study protocol and restrictions.
Participants taking any supplements (eg fish oil) and medications (eg statins/fibrates which could interfere with study parameters.
Presence of diabetes (as assessed from medical questionnaire fasting glucose great than 7mmol/L by fingerprick at screening)
Known lactose intolerance or dairy allergy.
Participation in a study within 30 days of commencement of the study.
Weight changes of more than 3kg over last 3 months.
History of Cardiovascular disease.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants are screened for inclusion and exclusion criteria and once deemed eligible are randomly allocated into one of the 4 treatment orders. Allocation was concealed by central randomisation by computer.</concealment>
    <sequence>Random allocation using the computer software "Clinstat".</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>9/02/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Kraft Foods</primarysponsorname>
    <primarysponsoraddress>162 Salmon St
Port Melbourne  VIC 3207</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Kraft Foods</fundingname>
      <fundingaddress>162 Salmon St
Port Melbourne  VIC 3207</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>Commonwealth Scientific Industrial Research Organisation (CSIRO) Human Nutrition</sponsorname>
      <sponsoraddress>Gate 13 Kintore Ave
Adelaide SA 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CSIRO Human Research Ethics Committee</ethicname>
      <ethicaddress>Gate 13 Kintore Ave
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>12/12/2008</ethicapprovaldate>
      <hrec>08/19</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Peter Clifton</name>
      <address>CSIRO Human Nutrition
Gate 13 Kintore Ave
Adelaide  SA  5000</address>
      <phone>+61 8 8303 8826</phone>
      <fax>+61 8 83038899</fax>
      <email>peter.clifton@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anne McGuffin</name>
      <address>CSIRO Human Nutrition
Gate 13 Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 8 83038988</phone>
      <fax>+61 8 8303 8899</fax>
      <email>anne.mcguffin@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anne McGuffin</name>
      <address>CSIRO Human Nutrition
Gate 13 Kintore Ave
Adelaide  SA  5000</address>
      <phone>+61 8 83038988</phone>
      <fax>+61 8 8303 8899</fax>
      <email>anne.mcguffin@csiro.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>